| 4001 | Kela-code for severe mental illness | FING00000707 | 3.15 |
| 4002 | LDL (standard GWA) | GCST90267272 | 3.15 |
| 4003 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T313 | ECGU000313 | 3.15 |
| 4004 | Systolic blood pressure | GCST90310294 | 3.15 |
| 4005 | Pulse pressure | GCST90472785 | 3.15 |
| 4006 | Sphingomyelin_40:2_[M+H]1+ levels | GCST90060352 | 3.15 |
| 4007 | Disorders of skin appendages | FING00000460 | 3.15 |
| 4008 | GPNMB levels | GCST90469393 | 3.14 |
| 4009 | Hypertension, essential | FING00000638 | 3.14 |
| 4010 | Etiocholanolone glucuronide levels | GCST90199964 | 3.14 |
| 4011 | wg rh intensity-contrast parstriangularis | GCST90003846 | 3.14 |
| 4012 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T387 | ECGA000387 | 3.14 |
| 4013 | Average diameter for VLDL particles | GCST90500290 | 3.14 |
| 4014 | Retinal thickness (functional principal component 1) | GCST90455721 | 3.13 |
| 4015 | IDP dMRI ProbtrackX L2 cgc r | GCST90004278 | 3.13 |
| 4016 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 67) | GCST90320886 | 3.13 |
| 4017 | LTBP2 levels | GCST90469814 | 3.13 |
| 4018 | IDP dMRI TBSS OD Cerebral peduncle L | GCST90004417 | 3.13 |
| 4019 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T327 | ECGA000327 | 3.13 |
| 4020 | Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk | FING00000150 | 3.13 |
| 4021 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T277 | ECGU000277 | 3.13 |
| 4022 | Phospholipids in VLDL | GCST90500268 | 3.12 |
| 4023 | Left-hemisphere salience/ventral attention network to caudate white-matter structural connectivity | GCST90302720 | 3.12 |
| 4024 | Hereditary hemolytic anemias (PheCode 282) | GCST90475779 | 3.12 |
| 4025 | Coronary atherosclerosis (PheCode 411.4) | GCST90043957 | 3.12 |
| 4026 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T302 | ECGA000302 | 3.12 |
| 4027 | Prescriptions - amlodipine | calcium channel blocker,dihydropyridine,anti-hypertensive | UKBB00000660 | 3.12 |
| 4028 | Hyphaema and other vascular disorders of iris and ciliary body | FING00000647 | 3.12 |
| 4029 | Diastolic blood pressure | GCST90472779 | 3.11 |
| 4030 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T388 | ECGA000388 | 3.11 |
| 4031 | Principal component-derived dietary pattern 32 | GCST90133037 | 3.11 |
| 4032 | Gamma-CEHC levels | GCST90199864 | 3.10 |
| 4033 | Emphysema | FING00000496 | 3.10 |
| 4034 | Omega-3 fatty acids to total fatty acids percentage | GCST90502081 | 3.10 |
| 4035 | IDP dMRI ProbtrackX FA fmi | GCST90003936 | 3.10 |
| 4036 | aseg lh volume Putamen | GCST90002622 | 3.10 |
| 4037 | Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22) | GCST90475991 | 3.10 |
| 4038 | wg rh intensity-contrast inferiorparietal | GCST90003834 | 3.10 |
| 4039 | CDH2/CDHR2 ratio | GCST90313950 | 3.10 |
| 4040 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T333 | ECGA000333 | 3.09 |
| 4041 | Non-cancer illness code, self-reported - angina | Medical conditions | UKBB00000505 | 3.09 |
| 4042 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T389 | ECGA000389 | 3.09 |
| 4043 | Free Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500598 | 3.09 |
| 4044 | DTI TBSS MD Fornix cres+Stria terminalis L | GCST90384611 | 3.08 |
| 4045 | DTI TBSS L3 Uncinate fasciculus R | GCST90384568 | 3.08 |
| 4046 | Triglycerides | Blood biochemistry | UKBB00000861 | 3.08 |
| 4047 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T196 | ECGA000196 | 3.07 |
| 4048 | wg lh intensity-contrast parsopercularis | GCST90003809 | 3.07 |
| 4049 | ITGB1/TFPI ratio | GCST90315231 | 3.07 |
| 4050 | FLT3 levels | GCST90469251 | 3.07 |
| 4051 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T334 | ECGA000334 | 3.07 |
| 4052 | DSG4 levels | GCST90469044 | 3.06 |
| 4053 | SLC5A8 levels | GCST90242850 | 3.06 |
| 4054 | Cystitis | FING00000376 | 3.06 |
| 4055 | Hemorrhagic fever with renal syndrome | GCST90454190 | 3.06 |
| 4056 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T173 | ECGU000173 | 3.06 |
| 4057 | YES1 levels | GCST90471088 | 3.06 |
| 4058 | Diacylglycerol_36:4_[M+H-H2O]1+ levels | GCST90060188 | 3.05 |
| 4059 | MDK levels | GCST90469877 | 3.05 |
| 4060 | VEGFA levels | GCST90011995 | 3.05 |
| 4061 | Hyperparathyroidism (PheCode 252.1) | GCST90475693 | 3.05 |
| 4062 | ULBP2 levels | GCST90471008 | 3.04 |
| 4063 | MIA/NBL1 ratio | GCST90315445 | 3.04 |
| 4064 | SPINK6 levels | GCST90470725 | 3.04 |
| 4065 | Venous thromboembolism | FING00001427 | 3.04 |
| 4066 | Cerebrovascular disease (PheCode 433) | GCST90475985 | 3.04 |
| 4067 | T1 FreeSurfer aseg Left-choroid-plexus | GCST90384156 | 3.04 |
| 4068 | Operative procedures - Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract | Summary Operations | UKBB00000578 | 3.04 |
| 4069 | Glucose | Blood biochemistry | UKBB00000288 | 3.04 |
| 4070 | Red cell distribution width | GCST006804 | 3.04 |
| 4071 | Other disorders of cornea | FING00001022 | 3.03 |
| 4072 | IDP dMRI ProbtrackX L3 cst l | GCST90004308 | 3.03 |
| 4073 | CXCL6/DFFA ratio | GCST90314357 | 3.03 |
| 4074 | Triglyceride to HDL cholesterol ratio | GCST90295949 | 3.03 |
| 4075 | Alcohol-related disorders | mental disorders | UKBB00000026 | 3.03 |
| 4076 | DTI TBSS MD Superior corona radiata R | GCST90384596 | 3.02 |
| 4077 | ISLR2 levels | GCST90469629 | 3.02 |
| 4078 | PI16 levels | GCST90470229 | 3.02 |
| 4079 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118) | GCST90320937 | 3.02 |
| 4080 | Irritable bowel syndrome | GCST90243958 | 3.01 |
| 4081 | Plasma mannonate* levels in chronic kidney disease | GCST90265479 | 3.01 |
| 4082 | high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed) | GCST90475354 | 3.01 |
| 4083 | Other functional intestinal disorders | FING00001052 | 3.00 |
| 4084 | Triglyceride levels in VLDL | GCST90093003 | 3.00 |
| 4085 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90093044 | 3.00 |
| 4086 | RND3 levels | GCST90618066 | 3.00 |
| 4087 | DAPP1/ITGB1BP2 ratio | GCST90314388 | 2.99 |
| 4088 | Mental and behavioural disorders due to use of tobacco | Mental and behavioural disorders due to psychoactive substance use | UKBB00000460 | 2.99 |
| 4089 | Cholesteryl Esters to Total Lipids in Very Large VLDL percentage | GCST90500569 | 2.98 |
| 4090 | Total lipid levels in very large VLDL | GCST90093022 | 2.98 |
| 4091 | Other and unspecified nerve root and plexus disorders, also in other diseases | FING00000944 | 2.98 |
| 4092 | Principal component-derived dietary pattern 11 | GCST90133016 | 2.98 |
| 4093 | MITD1/RHOC ratio | GCST90315453 | 2.98 |
| 4094 | IDP dMRI ProbtrackX ICVF slf l | GCST90004396 | 2.98 |
| 4095 | IDP dMRI TBSS ICVF Uncinate fasciculus L | GCST90004372 | 2.97 |
| 4096 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T169 | ECGU000169 | 2.97 |
| 4097 | Severe hearing loss or partial deafness in one or both ears | GCST90475385 | 2.97 |
| 4098 | BCAM/NOTCH1 ratio | GCST90313474 | 2.97 |
| 4099 | CD40LG/EREG ratio | GCST90313820 | 2.96 |
| 4100 | Total lipids in IDL | GCST90497594 | 2.96 |
| 4101 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T454 | ECGA000454 | 2.96 |
| 4102 | BCAM/CLEC14A ratio | GCST90313470 | 2.96 |
| 4103 | wg lh intensity-contrast middletemporal | GCST90003806 | 2.96 |
| 4104 | CX3CL1 levels | GCST90274778 | 2.96 |
| 4105 | IFNGR1/THBD ratio | GCST90315130 | 2.95 |
| 4106 | Number of treatments/medications taken | Medications | UKBB00000542 | 2.95 |
| 4107 | FOLH1 levels | GCST90425661 | 2.95 |
| 4108 | Left ventricular outflow tract obstruction, narrow definition | FING00000718 | 2.95 |
| 4109 | Polyunsaturated fatty acid levels | GCST90499266 | 2.95 |
| 4110 | IDP dMRI TBSS ICVF Anterior corona radiata L | GCST90004350 | 2.95 |
| 4111 | DDR1/PVR ratio | GCST90314442 | 2.95 |
| 4112 | Number of attempts | Prospective memory | UKBB00000531 | 2.94 |
| 4113 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T180 | ECGU000180 | 2.94 |
| 4114 | AMY2B levels | GCST90468299 | 2.94 |
| 4115 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T407 | ECGU000407 | 2.94 |
| 4116 | Phospholipids in large VLDL (UKB data field 23497) | GCST90269594 | 2.94 |
| 4117 | IDP T1 SIENAX peripheral grey unnormalised volume | GCST90002427 | 2.94 |
| 4118 | Physical activity (confirmatory factor analysis Factor 23) | GCST90309357 | 2.94 |
| 4119 | DTI TBSS L1 External capsule R | GCST90384460 | 2.93 |
| 4120 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T374 | ECGU000374 | 2.93 |
| 4121 | Left-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302678 | 2.93 |
| 4122 | Diabetes mellitus (UKB data field 2443) | GCST90043627 | 2.93 |
| 4123 | Right ventricular end systolic volume | GCST90134589 | 2.93 |
| 4124 | Linoleic acid levels | GCST90502307 | 2.93 |
| 4125 | aparc-Desikan rh area parsopercularis | GCST90003124 | 2.92 |
| 4126 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T179 | ECGA000179 | 2.92 |
| 4127 | Phospholipids to Total Lipids in IDL percentage | GCST90497642 | 2.92 |
| 4128 | F-strong alcohol liking (derived food-liking factor) | GCST90094850 | 2.92 |
| 4129 | Glycated hemoglobin levels | GCST90002243 | 2.92 |
| 4130 | SSC-A on plasmacytoid Dendritic Cell | GCST90002072 | 2.92 |
| 4131 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T314 | ECGU000314 | 2.92 |
| 4132 | Atherosclerosis, excluding cerebral and coronary sclerosis | FING00000123 | 2.92 |
| 4133 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T223 | ECGU000223 | 2.92 |
| 4134 | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levels | GCST90200083 | 2.92 |
| 4135 | Left ventricular wall thickness (mean) | GCST90435264 | 2.91 |
| 4136 | GRN levels | GCST90469404 | 2.91 |
| 4137 | Vigorous physical activity | GCST006098 | 2.91 |
| 4138 | LBR/MAD1L1 ratio | GCST90315295 | 2.91 |
| 4139 | Diacylglycerol_34:2_[M+H-H2O]1+ levels | GCST90060178 | 2.91 |
| 4140 | OSMR levels | GCST90470132 | 2.91 |
| 4141 | wg lh intensity-contrast superiorfrontal | GCST90003819 | 2.91 |
| 4142 | CRELD1 levels | GCST90468858 | 2.91 |
| 4143 | Total lipids in large VLDL (UKB data field 23496) | GCST90269593 | 2.91 |
| 4144 | aparc-Desikan rh volume parahippocampal | GCST90002816 | 2.91 |
| 4145 | Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000811 | 2.91 |
| 4146 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T467 | ECGA000467 | 2.91 |
| 4147 | Shoulder width to body height ratio | GCST90270261 | 2.90 |
| 4148 | Osteoporosis (PheCode 743.1) | GCST90476384 | 2.90 |
| 4149 | LRP11/NECTIN2 ratio | GCST90315329 | 2.90 |
| 4150 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T195 | ECGA000195 | 2.90 |
| 4151 | DAPK2 levels | GCST90468945 | 2.90 |
| 4152 | Low density lipoprotein cholesterol levels | GCST90239657 | 2.89 |
| 4153 | AV-block | FING00000137 | 2.89 |
| 4154 | Coronary artery calcification | GCST90278456 | 2.89 |
| 4155 | Alzheimer's disease (MTAG) | GCST90449055 | 2.89 |
| 4156 | CDH17 levels | GCST90468669 | 2.89 |
| 4157 | APCS levels | GCST90428463 | 2.89 |
| 4158 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T16 | ECGU000016 | 2.89 |
| 4159 | DTI TBSS FA Anterior corona radiata L | GCST90384403 | 2.89 |
| 4160 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T466 | ECGA000466 | 2.89 |
| 4161 | Medication use (salicylic acid and derivatives) | GCST90018775 | 2.88 |
| 4162 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T261 | ECGA000261 | 2.88 |
| 4163 | IGFBP1 levels | GCST90469527 | 2.88 |
| 4164 | Disorders of breast | FING00000437 | 2.88 |
| 4165 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T168 | ECGU000168 | 2.87 |
| 4166 | Handedness (confirmatory factor analysis Factor 36) | GCST90309370 | 2.87 |
| 4167 | IDP dMRI TBSS L3 Body of corpus callosum | GCST90004174 | 2.87 |
| 4168 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T409 | ECGU000409 | 2.86 |
| 4169 | Plantar fascial fibromatosis | FING00001169 | 2.86 |
| 4170 | DTI TBSS L3 Anterior limb of internal capsule L | GCST90384541 | 2.86 |
| 4171 | FIS1/HSPA1A ratio | GCST90314825 | 2.86 |
| 4172 | PM: initial answer - Blue square | Prospective memory | UKBB00000651 | 2.86 |
| 4173 | Female infertility, cervigal, vaginal, other or unspecified origin | FING00000538 | 2.86 |
| 4174 | IDP dMRI ProbtrackX MO atr r | GCST90004003 | 2.86 |
| 4175 | Free cholesterol levels in very large VLDL | GCST90093020 | 2.86 |
| 4176 | Monounsaturated fatty acid levels | GCST90502346 | 2.86 |
| 4177 | Other strabismus | FING00001114 | 2.86 |
| 4178 | IDP T1 FAST ROIs R occ pole | GCST90002546 | 2.86 |
| 4179 | Retinal thickness (functional principal component 6) | GCST90455726 | 2.85 |
| 4180 | wg lh intensity-contrast fusiform | GCST90003798 | 2.85 |
| 4181 | Phospholipids in very small VLDL | GCST90500840 | 2.84 |
| 4182 | Other abnormal uterine and vaginal bleeding | FING00000919 | 2.84 |
| 4183 | Other diseases of intestine | Other diseases of intestines | UKBB00000605 | 2.84 |
| 4184 | Mean corpuscular hemoglobin concentration | GCST90002391 | 2.84 |
| 4185 | ADGRE2/B4GALT1 ratio | GCST90313174 | 2.83 |
| 4186 | DAPP1 levels | GCST90468946 | 2.83 |
| 4187 | aparc-DKTatlas rh volume parahippocampal | GCST90002907 | 2.83 |
| 4188 | wg lh intensity-contrast superiortemporal | GCST90003821 | 2.83 |
| 4189 | Placental weight (paternal genotype, adjusted for sex) | GCST90275199 | 2.83 |
| 4190 | Ectopic pregnancy | FING00000487 | 2.82 |
| 4191 | MAP2K6/TBL1X ratio | GCST90315378 | 2.82 |
| 4192 | IDP dMRI TBSS MD Sagittal stratum R | GCST90004057 | 2.82 |
| 4193 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T469 | ECGA000469 | 2.82 |
| 4194 | RECK levels | GCST90470445 | 2.82 |
| 4195 | Other extrapyramidal and movement disorders in other diseases | FING00001047 | 2.82 |
| 4196 | Time spend outdoors in summer | Sun exposure | UKBB00000817 | 2.82 |
| 4197 | Sleep disorders (PheCode 327) | GCST90475823 | 2.81 |
| 4198 | Right-hemisphere default mode network to thalamus white-matter structural connectivity | GCST90302844 | 2.81 |
| 4199 | SEPTIN3 levels | GCST90470576 | 2.81 |
| 4200 | Concentration of large VLDL particles | GCST90092875 | 2.81 |
| 4201 | Chronic Kidney Disease, Stage III (PheCode 585.33) | GCST90476128 | 2.80 |
| 4202 | Linoleic acid to total fatty acids percentage | GCST90502336 | 2.80 |
| 4203 | LDL cholesterol levels | GCST90498346 | 2.80 |
| 4204 | Duration of vigorous activity | Physical activity | UKBB00000199 | 2.80 |
| 4205 | Total lipids in medium VLDL | GCST90498994 | 2.80 |
| 4206 | Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000440 | 2.80 |
| 4207 | Ever thought that life not worth living | Self-harm behaviours | UKBB00000225 | 2.79 |
| 4208 | End-diastolic bi-ventricular shape (principal component 1) | GCST90448480 | 2.79 |
| 4209 | aparc-DKTatlas rh area parsopercularis | GCST90003281 | 2.79 |
| 4210 | PLSCR3 levels | GCST90470261 | 2.78 |
| 4211 | Blood cell traits latent factor 2 (red cell) | GCST90559244 | 2.78 |
| 4212 | DNAJB14 levels | GCST90427235 | 2.78 |
| 4213 | Alcohol usually taken with meals (UKB data field 1618) | GCST90133004 | 2.78 |
| 4214 | Hearing difficulty problems background noise (UKB data field 2257) | GCST90042885 | 2.78 |
| 4215 | Bone marrow fat fraction of lumbar vertebra 1 | GCST90652386 | 2.78 |
| 4216 | Body-mass index, inverse-rank normalized | FING00000222 | 2.78 |
| 4217 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T235 | ECGU000235 | 2.78 |
| 4218 | aseg lh intensity Pallidum | GCST90003771 | 2.78 |
| 4219 | Other eye problems | Eyesight | UKBB00000610 | 2.77 |
| 4220 | Total cholesterol minus HDL-C levels | GCST90499129 | 2.77 |
| 4221 | DTI autoptx L1 atr l tract | GCST90385141 | 2.77 |
| 4222 | VCAN levels | GCST90471032 | 2.77 |
| 4223 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T170 | ECGU000170 | 2.77 |
| 4224 | MBL2 levels | GCST90469868 | 2.77 |
| 4225 | SNCA levels | GCST90470694 | 2.77 |
| 4226 | AXIN1/MAP2K6 ratio | GCST90313413 | 2.77 |
| 4227 | IDP dMRI TBSS ICVF Posterior thalamic radiation R | GCST90004355 | 2.76 |
| 4228 | 3-(4-hydroxyphenyl)lactate levels | GCST90243575 | 2.76 |
| 4229 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T165 | ECGU000165 | 2.76 |
| 4230 | SUGT1/TBL1X ratio | GCST90315897 | 2.76 |
| 4231 | Retinoschisis and retinal cysts (PheCode 361.2) | GCST90475846 | 2.76 |
| 4232 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T417 | ECGU000417 | 2.76 |
| 4233 | Hypo-osmolality and hyponatraemia | FING00000648 | 2.76 |
| 4234 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45) | GCST90320608 | 2.75 |
| 4235 | Volume of right medial nucleus | GCST90475042 | 2.75 |
| 4236 | Osteomyelitis (PheCode 710.1) | GCST90476221 | 2.75 |
| 4237 | total creatine kinase (maximum, inv-norm transformed) | GCST90476410 | 2.75 |
| 4238 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502388 | 2.75 |
| 4239 | CREG1/NAAA ratio | GCST90314250 | 2.75 |
| 4240 | Triglyceride levels in medium HDL | GCST90092902 | 2.75 |
| 4241 | HLA-A levels | GCST90469457 | 2.74 |
| 4242 | Hallux valgus (Bunion) (PheCode 735.3) | GCST90476251 | 2.74 |
| 4243 | Cholesteryl ester_16:0_[M+NH4]1+ levels | GCST90060211 | 2.74 |
| 4244 | Platelet count during first trimester of pregnancy | GCST90302224 | 2.74 |
| 4245 | SLITRK6 levels | GCST90470671 | 2.74 |
| 4246 | Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000812 | 2.73 |
| 4247 | Other septicaemia | FING00001097 | 2.73 |
| 4248 | SEMA4D/TXNDC5 ratio | GCST90315824 | 2.73 |
| 4249 | Ground coffee consumption | GCST90132976 | 2.73 |
| 4250 | Hippocampal subfield right CA1 volume (head) | GCST90267961 | 2.73 |
| 4251 | Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2) | GCST90044025 | 2.73 |
| 4252 | IDP T1 FIRST right putamen volume | GCST90002441 | 2.72 |
| 4253 | Hypermetropia (PheCode 367.8) | GCST90475882 | 2.72 |
| 4254 | LRRC59 levels | GCST90469804 | 2.72 |
| 4255 | Right-hemisphere default mode network to caudate white-matter structural connectivity | GCST90302845 | 2.72 |
| 4256 | Exophthalmic conditions | FING00000526 | 2.72 |
| 4257 | DMP1 levels | GCST90469007 | 2.72 |
| 4258 | CD244/GP1BA ratio | GCST90313766 | 2.72 |
| 4259 | Left-hemisphere control network to right-hemisphere default mode network white-matter structural connectivity | GCST90302751 | 2.72 |
| 4260 | Total testosterone levels | GCST90012114 | 2.72 |
| 4261 | Orange juice liking | GCST90094806 | 2.72 |
| 4262 | GSTT2B levels | GCST90469415 | 2.72 |
| 4263 | Sodium in urine | Urine assays | UKBB00000785 | 2.71 |
| 4264 | HEXIM1/NUB1 ratio | GCST90315049 | 2.71 |
| 4265 | Cerebral aneurysm, nonruptured | FING00000263 | 2.71 |
| 4266 | Apple juice liking | GCST90094690 | 2.71 |
| 4267 | 1-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levels | GCST90200046 | 2.71 |
| 4268 | Enterocolitis due to Clostridium difficile | FING00000507 | 2.71 |
| 4269 | NGRN levels | GCST90470045 | 2.71 |
| 4270 | ThalamNuclei rh volume MDl | GCST90002748 | 2.71 |
| 4271 | Mean arterial pressure, manual reading | Cardiovascular measurement | UKBB00000442 | 2.71 |
| 4272 | Pain in limb (PheCode 773) | GCST90476270 | 2.71 |
| 4273 | SNX18 levels | GCST90470700 | 2.70 |
| 4274 | Glutamine levels | GCST90497285 | 2.70 |
| 4275 | Corneal resistance factor (right) | Intraocular pressure | UKBB00000151 | 2.70 |
| 4276 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64) | GCST90320627 | 2.70 |
| 4277 | Glucosamine medication | FING00000584 | 2.70 |
| 4278 | Erectile dysfunction [ED] (PheCode 605) | GCST90476161 | 2.70 |
| 4279 | Physical decline (log-difference score) | GCST90565847 | 2.69 |
| 4280 | Total lipids in medium HDL | GCST90498597 | 2.69 |
| 4281 | Cerebral amyloid angiopathy | FING00000262 | 2.69 |
| 4282 | Triglycerides in large LDL (UKB data field 23536) | GCST90269633 | 2.69 |
| 4283 | DNA methylation Hannum age acceleration | GCST90014289 | 2.69 |
| 4284 | ADGRE5 levels | GCST90468238 | 2.69 |
| 4285 | Cardiac pacemaker in situ (PheCode 426.91) | GCST90475960 | 2.69 |
| 4286 | Testosterone | Blood biochemistry | UKBB00000816 | 2.68 |
| 4287 | CALCOCO1/PFKFB2 ratio | GCST90313608 | 2.68 |
| 4288 | Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000439 | 2.68 |
| 4289 | Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482) | GCST90269579 | 2.68 |
| 4290 | Dyslipidemia | GCST90086077 | 2.68 |
| 4291 | Prescriptions - alpha1-antagonist|alpha blocker | UKBB00000659 | 2.68 |
| 4292 | aparc-DKTatlas lh area precuneus | GCST90003257 | 2.67 |
| 4293 | EBAG9/EDAR ratio | GCST90314563 | 2.67 |
| 4294 | FAM3C/NECTIN2 ratio | GCST90314781 | 2.67 |
| 4295 | F9 levels | GCST90469172 | 2.67 |
| 4296 | Total fatty acid levels | GCST90502212 | 2.67 |
| 4297 | LGALS8 levels | GCST90469764 | 2.67 |
| 4298 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 106) | GCST90320925 | 2.67 |
| 4299 | Clinical anxiety and depression (confirmatory factor analysis Factor 3) | GCST90309338 | 2.67 |
| 4300 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229 | ECGU000229 | 2.66 |
| 4301 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T243 | ECGU000243 | 2.66 |
| 4302 | CDKN2D/ITGB1BP2 ratio | GCST90313987 | 2.66 |
| 4303 | Diastolic blood pressure | GCST90472777 | 2.65 |
| 4304 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T461 | ECGA000461 | 2.65 |
| 4305 | BCAM levels | GCST90468425 | 2.65 |
| 4306 | CD69/PPP1R2 ratio | GCST90313882 | 2.65 |
| 4307 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T390 | ECGA000390 | 2.65 |
| 4308 | Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484) | GCST90269581 | 2.65 |
| 4309 | Free Cholesterol to Total Lipids in IDL percentage | GCST90497579 | 2.65 |
| 4310 | Cholesterol in Small LDL | GCST90499559 | 2.65 |
| 4311 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T188 | ECGA000188 | 2.65 |
| 4312 | Abnormality of gait (PheCode 350.2) | GCST90475841 | 2.64 |
| 4313 | ART3/GPC1 ratio | GCST90313361 | 2.64 |
| 4314 | aseg global volume 3rd-Ventricle | GCST90002599 | 2.64 |
| 4315 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T398 | ECGU000398 | 2.64 |
| 4316 | TPI1 levels | GCST90088659 | 2.64 |
| 4317 | Fluid intelligence score decline (log-difference score) | GCST90565852 | 2.64 |
| 4318 | HPCAL1/NUDC ratio | GCST90315074 | 2.64 |
| 4319 | TNFRSF11B/TNFSF11 ratio | GCST90315930 | 2.63 |
| 4320 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T231 | ECGU000231 | 2.63 |
| 4321 | 5,6-dihydrouridine levels | GCST90199767 | 2.63 |
| 4322 | Estradiol levels | GCST90020091 | 2.63 |
| 4323 | DDR1 levels | GCST90468970 | 2.63 |
| 4324 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T462 | ECGU000462 | 2.63 |
| 4325 | Angina | GCST90468109 | 2.62 |
| 4326 | Fluid intelligence score (baseline) | GCST90565842 | 2.62 |
| 4327 | OSCAR/TNFRSF14 ratio | GCST90315588 | 2.62 |
| 4328 | CAG-776 sp000438195 abundance in stool | GCST90032296 | 2.62 |
| 4329 | CXADR/MME ratio | GCST90314329 | 2.62 |
| 4330 | ARG1 levels | GCST90468350 | 2.62 |
| 4331 | Cataract | sense organs | UKBB00000120 | 2.62 |
| 4332 | Excessive hairiness | GCST006095 | 2.62 |
| 4333 | 3-hydroxybutyrate levels (UKB data field 23474) | GCST90269571 | 2.62 |
| 4334 | TNFRSF11A levels | GCST90470902 | 2.62 |
| 4335 | Concentration of very large VLDL particles | GCST90093023 | 2.61 |
| 4336 | HDL cholesterol levels (UKB data field 30760) | GCST90468075 | 2.61 |
| 4337 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T291 | ECGU000291 | 2.61 |
| 4338 | CDKN1A/ENO2 ratio | GCST90313969 | 2.61 |
| 4339 | Total Phosphatidylethanolamine levels | GCST90025207 | 2.61 |
| 4340 | Bone marrow fat fraction of thoracic vertebra 10 | GCST90652382 | 2.61 |
| 4341 | Triglycerides in medium LDL (UKB data field 23543) | GCST90269640 | 2.61 |
| 4342 | Androstenediol (3beta,17beta) disulfate (1) levels | GCST90199842 | 2.61 |
| 4343 | Antihypertensive medication - note that there are other indications | FING00000097 | 2.61 |
| 4344 | wg lh intensity-contrast rostralmiddlefrontal | GCST90003818 | 2.61 |
| 4345 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T459 | ECGA000459 | 2.61 |
| 4346 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T415 | ECGA000415 | 2.61 |
| 4347 | GPR37 levels | GCST90469397 | 2.60 |
| 4348 | CD244/CD84 ratio | GCST90313762 | 2.60 |
| 4349 | SRC/STAT5B ratio | GCST90315882 | 2.60 |
| 4350 | Diabetes | GCST90468124 | 2.60 |
| 4351 | IDP dMRI ProbtrackX MD slf r | GCST90004241 | 2.60 |
| 4352 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90499287 | 2.59 |
| 4353 | Nephritis and nephropathy without mention of glomerulonephritis (PheCode 580.3) | GCST90476115 | 2.59 |
| 4354 | Docosahexaenoic acid to total fatty acids percentage | GCST90501997 | 2.59 |
| 4355 | Nap during day | Sleep | UKBB00000492 | 2.59 |
| 4356 | IDP dMRI ProbtrackX ISOVF fmi | GCST90004536 | 2.58 |
| 4357 | CXCL1 levels | GCST90012019 | 2.58 |
| 4358 | Monounsaturated fatty acid levels | GCST90499090 | 2.58 |
| 4359 | MAVS/MED18 ratio | GCST90315389 | 2.58 |
| 4360 | DTI autoptx FA ilf l tract | GCST90385126 | 2.58 |
| 4361 | Endometriosis | GCST90018619 | 2.58 |
| 4362 | Pure hypercholesterolaemia | FING00001230 | 2.58 |
| 4363 | CPXM1/DKK1 ratio | GCST90314218 | 2.58 |
| 4364 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T478 | ECGU000478 | 2.58 |
| 4365 | DTI TBSS FA Superior longitudinal fasciculus R | GCST90384420 | 2.58 |
| 4366 | CAG-177 sp003538135 abundance in stool | GCST90032260 | 2.57 |
| 4367 | Phospholipids in very small VLDL (UKB data field 23518) | GCST90269615 | 2.57 |
| 4368 | Total lipid levels in large VLDL | GCST90092874 | 2.57 |
| 4369 | Phospholipids to total lipids ratio in very small VLDL | GCST90093037 | 2.57 |
| 4370 | Saturated fatty acids to total fatty acids percentage | GCST90502701 | 2.57 |
| 4371 | IDP dMRI ProbtrackX L2 ptr l | GCST90004292 | 2.57 |
| 4372 | Left-hemisphere control network to left-hemisphere default mode network white-matter structural connectivity | GCST90302744 | 2.57 |
| 4373 | Osteoarthrosis NOS (PheCode 740.9) | GCST90476256 | 2.56 |
| 4374 | Frailty (Factor 4 - Metabolic Problems) | GCST90624050 | 2.56 |
| 4375 | SDC1 levels | GCST90470558 | 2.56 |
| 4376 | Paroxysmal tachycardia | FING00001151 | 2.56 |
| 4377 | MGLL/PDLIM7 ratio | GCST90315438 | 2.56 |
| 4378 | 1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels | GCST90200692 | 2.56 |
| 4379 | IZUMO4 levels | GCST90423792 | 2.56 |
| 4380 | CDON levels | GCST90468687 | 2.56 |
| 4381 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T14 | ECGU000014 | 2.55 |
| 4382 | rfMRI amplitudes (ICA100 node 12) | GCST90004600 | 2.55 |
| 4383 | AMBP/ASGR1 ratio | GCST90313251 | 2.55 |
| 4384 | NH4_C22:4 Cholesteryl ester levels in chronic kidney disease | GCST90257227 | 2.55 |
| 4385 | Triglycerides in VLDL | GCST90500304 | 2.55 |
| 4386 | Red blood cell erythrocyte distribution width (UKB data field 30070) | GCST90468099 | 2.55 |
| 4387 | Haemoglobin concentration (UKB data field 30020) | GCST90468074 | 2.55 |
| 4388 | Triacylglycerol_52:1_[M+NH4]1+ levels | GCST90060515 | 2.55 |
| 4389 | Total triglycerides levels | GCST90500126 | 2.55 |
| 4390 | Cholesteryl Esters in LDL | GCST90498374 | 2.54 |
| 4391 | Treatment or medication use - insulin product (UKB data field 20003_1140883066) | GCST90042226 | 2.54 |
| 4392 | Volume of right basal nucleus | GCST90475015 | 2.54 |
| 4393 | Acetoacetate levels (UKB data field 23476) | GCST90269573 | 2.54 |
| 4394 | IDP dMRI ProbtrackX ICVF ilf l | GCST90004389 | 2.54 |
| 4395 | Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levels | GCST90200098 | 2.54 |
| 4396 | aparc-Desikan lh area precuneus | GCST90003097 | 2.54 |
| 4397 | aseg global volume SupraTentorialNotVent | GCST90002596 | 2.54 |
| 4398 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 50) | GCST90320613 | 2.54 |
| 4399 | Free Cholesterol to Total Lipids in Large VLDL percentage | GCST90498204 | 2.53 |
| 4400 | Illnesses of mother: Alzheimer's disease/dementia (UKB data field 20110_10) | GCST90042678 | 2.53 |
| 4401 | Vascular/heart problems diagnosed by doctor - High blood pressure | Medical conditions | UKBB00000898 | 2.53 |
| 4402 | Mean corpuscular hemoglobin concentration | GCST90002328 | 2.53 |
| 4403 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T455 | ECGA000455 | 2.53 |
| 4404 | IDP dMRI TBSS FA Anterior limb of internal capsule L | GCST90003894 | 2.53 |
| 4405 | Eye problems/disorders - Cataract | Eyesight | UKBB00000230 | 2.52 |
| 4406 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T408 | ECGU000408 | 2.52 |
| 4407 | CD40/GLOD4 ratio | GCST90313814 | 2.52 |
| 4408 | COL1A1 levels | GCST90468813 | 2.52 |
| 4409 | BA-exvivo rh thickness BA1 | GCST90003527 | 2.52 |
| 4410 | End-diastolic bi-ventricular shape (principal component 10) | GCST90448489 | 2.52 |
| 4411 | Concentration of medium HDL particles | GCST90498617 | 2.52 |
| 4412 | Other hearing loss | FING00001056 | 2.51 |
| 4413 | Monounsaturated fatty acids levels (UKB data field 23447) | GCST90269544 | 2.51 |
| 4414 | RCC1 levels | GCST90470443 | 2.51 |
| 4415 | CCL19 levels | GCST90274765 | 2.51 |
| 4416 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T413 | ECGA000413 | 2.51 |
| 4417 | MANF/NCK2 ratio | GCST90315359 | 2.51 |
| 4418 | MFGE8 levels | GCST90469900 | 2.51 |
| 4419 | Diseases of liver | FING00000425 | 2.51 |
| 4420 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T234 | ECGA000234 | 2.51 |
| 4421 | Saturated fatty acids levels | GCST90502194 | 2.51 |
| 4422 | IDP dMRI ProbtrackX L3 cst r | GCST90004309 | 2.51 |
| 4423 | Docosahexaenoic acid levels | GCST90502243 | 2.51 |
| 4424 | Leiomyoma of uterus | FING00000719 | 2.50 |
| 4425 | Bicuspidal aortic valve syndrome | FING00000212 | 2.50 |
| 4426 | Left-hemisphere salience/ventral attention network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302714 | 2.50 |
| 4427 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T406 | ECGU000406 | 2.50 |
| 4428 | aseg rh volume Caudate | GCST90002638 | 2.49 |
| 4429 | Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481) | GCST90269578 | 2.49 |
| 4430 | Concentration of chylomicrons and extremely large VLDL particles | GCST90501010 | 2.49 |
| 4431 | Acute alcohol intoxication | FING00000014 | 2.49 |
| 4432 | Metabolic syndrome | GCST009602 | 2.49 |
| 4433 | BLVRB/HMBS ratio | GCST90313526 | 2.49 |
| 4434 | GALNT10/SEMA7A ratio | GCST90314915 | 2.48 |
| 4435 | Cereal consumption (bowls per week) (UKB data field 1458) | GCST90132982 | 2.48 |
| 4436 | Hernia | FING00000616 | 2.48 |
| 4437 | IMPA1/TBCC ratio | GCST90315175 | 2.48 |
| 4438 | Principal component-derived dietary pattern 17 | GCST90133022 | 2.48 |
| 4439 | Diastolic blood pressure | GCST90018732 | 2.48 |
| 4440 | aparc-Desikan rh area inferiorparietal | GCST90003114 | 2.48 |
| 4441 | Neuroticism | GCST005232 | 2.47 |
| 4442 | Phospholipids to total lipids in large HDL percentage (UKB data field 23634) | GCST90269731 | 2.47 |
| 4443 | Sphingomyelin_40:3_[M+H]1+ levels | GCST90060348 | 2.47 |
| 4444 | Blood glucose levels | GCST90025986 | 2.47 |
| 4445 | BA-exvivo lh area BA2 | GCST90003208 | 2.47 |
| 4446 | Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary Operations | UKBB00000583 | 2.47 |
| 4447 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472 | ECGU000472 | 2.47 |
| 4448 | Hippocampal subfield left CA3 volume (head) | GCST90267941 | 2.47 |
| 4449 | Gestational thrombocytopenia | GCST90302234 | 2.46 |
| 4450 | Random glucose levels | GCST90271557 | 2.46 |
| 4451 | DTI autoptx L1 ilf l tract | GCST90385153 | 2.46 |
| 4452 | Osteoarthrosis (PheCode 740) | GCST90476253 | 2.46 |
| 4453 | NELL1 levels | GCST90242481 | 2.46 |
| 4454 | DTI TBSS L3 Anterior limb of internal capsule R | GCST90384540 | 2.46 |
| 4455 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 7) | GCST90320570 | 2.46 |
| 4456 | Total fatty acid levels | GCST90502218 | 2.45 |
| 4457 | ATP5IF1/LYN ratio | GCST90313389 | 2.45 |
| 4458 | RET levels | GCST90470458 | 2.45 |
| 4459 | Phospholipid levels in very large VLDL | GCST90093024 | 2.45 |
| 4460 | Illnesses of mother - None of the above (group 1) | Family history | UKBB00000349 | 2.45 |
| 4461 | aparc-a2009s rh volume S-subparietal | GCST90003069 | 2.45 |
| 4462 | Cholesteryl Esters to Total Lipids in IDL percentage | GCST90497549 | 2.45 |
| 4463 | Cholesteryl Esters to Total Lipids in Medium VLDL percentage | GCST90498956 | 2.45 |
| 4464 | Cod liking | GCST90094736 | 2.45 |
| 4465 | GFER/TRIAP1 ratio | GCST90314921 | 2.45 |
| 4466 | ADIPOQ levels | GCST90468245 | 2.45 |
| 4467 | CTSZ levels | GCST90468918 | 2.45 |
| 4468 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T292 | ECGU000292 | 2.44 |
| 4469 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 71) | GCST90320634 | 2.44 |
| 4470 | aparc-Desikan rh volume parsopercularis | GCST90002818 | 2.44 |
| 4471 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T161 | ECGU000161 | 2.44 |
| 4472 | Spermatocele | FING00001319 | 2.44 |
| 4473 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T185 | ECGA000185 | 2.43 |
| 4474 | EDAR/YES1 ratio | GCST90314594 | 2.43 |
| 4475 | Never eat eggs, dairy, wheat, sugar - Sugar or foods/drinks containing sugar | Diet | UKBB00000501 | 2.43 |
| 4476 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T270 | ECGU000270 | 2.43 |
| 4477 | Total Lipids in LDL | GCST90498396 | 2.43 |
| 4478 | HEXIM1 levels | GCST90469447 | 2.43 |
| 4479 | T1 FIRST volume R Puta | GCST90383995 | 2.43 |
| 4480 | Cholesterol to total lipids in large LDL percentage (UKB data field 23615) | GCST90269712 | 2.42 |
| 4481 | Triglycerides to Total Lipids in Large VLDL percentage | GCST90498293 | 2.42 |
| 4482 | CPM/PCSK9 ratio | GCST90314216 | 2.42 |
| 4483 | Mineral and other dietary supplements - Glucosamine | Medication | UKBB00000473 | 2.42 |
| 4484 | GALNT7 levels | GCST90469299 | 2.42 |
| 4485 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T289 | ECGU000289 | 2.42 |
| 4486 | Red blood cell count | GCST90002364 | 2.41 |
| 4487 | Pulmonary embolism and infarction, acute (PheCode 415.11) | GCST90475946 | 2.41 |
| 4488 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T473 | ECGU000473 | 2.41 |
| 4489 | HippSubfield rh volume Whole-hippocampal-body | GCST90002709 | 2.41 |
| 4490 | Alcohol liking | GCST90094688 | 2.41 |
| 4491 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T484 | ECGU000484 | 2.41 |
| 4492 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T373 | ECGU000373 | 2.41 |
| 4493 | VSTM2L levels | GCST90471057 | 2.41 |
| 4494 | Falls in the last year | General health | UKBB00000235 | 2.40 |
| 4495 | OLR1 levels | GCST90012020 | 2.40 |
| 4496 | Total triglycerides levels | GCST90092992 | 2.40 |
| 4497 | Occupational creativity | GCST90308774 | 2.40 |
| 4498 | Statin medication | FING00001331 | 2.39 |
| 4499 | NTF4 levels | GCST90470095 | 2.39 |
| 4500 | DTI TBSS MD Superior longitudinal fasciculus L | GCST90384613 | 2.39 |
| 4501 | Triglycerides x depression interaction (2df test) | GCST90570679 | 2.39 |
| 4502 | Gonarthrosis, primary, with knee surgery | FING00000586 | 2.39 |
| 4503 | Saturated fatty acids to total fatty acids percentage | GCST90502207 | 2.39 |
| 4504 | Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500929 | 2.39 |
| 4505 | PTGDS levels | GCST90470368 | 2.38 |
| 4506 | aparc-Desikan lh area fusiform | GCST90003079 | 2.38 |
| 4507 | FURIN/INHBC ratio | GCST90314886 | 2.38 |
| 4508 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T294 | ECGA000294 | 2.38 |
| 4509 | Biliary atresia | GCST90296484 | 2.38 |
| 4510 | TNXB levels | GCST90470930 | 2.38 |
| 4511 | IDP dMRI TBSS ISOVF Superior longitudinal fasciculus R | GCST90004517 | 2.38 |
| 4512 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T424 | ECGU000424 | 2.38 |
| 4513 | PGA4 levels | GCST90470216 | 2.38 |
| 4514 | NTRK3/SCARF2 ratio | GCST90315571 | 2.38 |
| 4515 | aparc-a2009s lh area S-postcentral | GCST90003363 | 2.37 |
| 4516 | IGLL1 levels | GCST90241473 | 2.37 |
| 4517 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T17 | ECGU000017 | 2.37 |
| 4518 | Dementia, including avohilmo | FING00000395 | 2.36 |
| 4519 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T391 | ECGA000391 | 2.36 |
| 4520 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T255 | ECGU000255 | 2.36 |
| 4521 | Illnesses of father - None of the above (group 1) | Family history | UKBB00000345 | 2.36 |
| 4522 | Concentration of chylomicrons and extremely large VLDL particles | GCST90501015 | 2.35 |
| 4523 | Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500992 | 2.35 |
| 4524 | Cooked vegetables consumption | GCST90132977 | 2.35 |
| 4525 | THBD levels | GCST90470853 | 2.35 |
| 4526 | Cholesterol to Total Lipids in IDL percentage | GCST90497518 | 2.35 |
| 4527 | Prostate cancer | GCST90475185 | 2.35 |
| 4528 | Endometriosis of rectovaginal septum and vagina | FING00000503 | 2.35 |
| 4529 | Omega-6 fatty acid levels | GCST90502103 | 2.35 |
| 4530 | GHR levels | GCST90469342 | 2.35 |
| 4531 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T79 | ECGU000079 | 2.35 |
| 4532 | Systolic blood pressure (BMI unadjusted) | GCST90335162 | 2.35 |
| 4533 | ANXA11 levels | GCST90468315 | 2.35 |
| 4534 | DTI TBSS L2 Posterior corona radiata R | GCST90384502 | 2.34 |
| 4535 | Docosahexaenoic acid levels | GCST90501984 | 2.34 |
| 4536 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T405 | ECGU000405 | 2.34 |
| 4537 | F-savour/caloric food liking (derived food-liking factor) | GCST90094835 | 2.34 |
| 4538 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T178 | ECGA000178 | 2.34 |
| 4539 | Bread type - Wholemeal or wholegrain | Diet | UKBB00000107 | 2.34 |
| 4540 | IDP dMRI TBSS L1 Superior longitudinal fasciculus R | GCST90004115 | 2.34 |
| 4541 | Phospholipids in small HDL | GCST90499478 | 2.34 |
| 4542 | EREG/GYS1 ratio | GCST90314701 | 2.33 |
| 4543 | Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivity | GCST90302673 | 2.33 |
| 4544 | SLIT2 levels | GCST90470668 | 2.33 |
| 4545 | Fresh fruit consumption | GCST90132979 | 2.33 |
| 4546 | Urinary incontinence (PheCode 599.4) | GCST90476152 | 2.33 |
| 4547 | Cholesterol in Small VLDL | GCST90499746 | 2.33 |
| 4548 | HRG levels | GCST90469476 | 2.33 |
| 4549 | T1 CAT volume L PlanumPolare | GCST90384086 | 2.33 |
| 4550 | aseg lh intensity Lateral-Ventricle | GCST90003764 | 2.33 |
| 4551 | T1 FreeSurfer a2009s lh G precentral volume | GCST90384844 | 2.32 |
| 4552 | CALCOCO1 levels | GCST90468530 | 2.32 |
| 4553 | F-caffeinated/sweet liking (derived food-liking factor) | GCST90094720 | 2.32 |
| 4554 | Cerebrospinal fluid sulfate* levels | GCST90318056 | 2.32 |
| 4555 | Phospholipid levels in chylomicrons and extremely large VLDL | GCST90501031 | 2.32 |
| 4556 | C2/SSC5D ratio | GCST90313555 | 2.32 |
| 4557 | Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498919 | 2.32 |
| 4558 | Red cell distribution width | GCST90002404 | 2.32 |
| 4559 | Getting up in morning | Sleep | UKBB00000285 | 2.32 |
| 4560 | CDKN1A/FOXO1 ratio | GCST90313970 | 2.32 |
| 4561 | Phospholipids to Total Lipids in Large VLDL percentage | GCST90498252 | 2.32 |
| 4562 | Volume of right paralaminar nucleus | GCST90475051 | 2.32 |
| 4563 | Hemoglobin | GCST90278631 | 2.32 |
| 4564 | FOXO3/MAP3K5 ratio | GCST90314880 | 2.31 |
| 4565 | Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501045 | 2.31 |
| 4566 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T244 | ECGU000244 | 2.31 |
| 4567 | Chronic ischaemic heart disease | Ischaemic heart diseases | UKBB00000137 | 2.30 |
| 4568 | Paradoxical eczema in biologic-treated plaque psoriasis | GCST90162550 | 2.30 |
| 4569 | Osteoarthritis | GCST90468144 | 2.30 |
| 4570 | DTI TBSS MO Pontine crossing tract | GCST90384621 | 2.30 |
| 4571 | Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500920 | 2.30 |
| 4572 | APOM/ERBB3 ratio | GCST90313314 | 2.30 |
| 4573 | Percentage of trisyalated structures in total plasma glycans (GP97) | GCST90668541 | 2.29 |
| 4574 | IDP dMRI TBSS FA Body of corpus callosum | GCST90003880 | 2.29 |
| 4575 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2) | GCST90320565 | 2.29 |
| 4576 | End-diastolic bi-ventricular shape (principal component 8) | GCST90448487 | 2.29 |
| 4577 | Principal component-derived dietary pattern 29 | GCST90133034 | 2.28 |
| 4578 | IDP T1 FAST ROIs R cerebellum VIIIb | GCST90002583 | 2.28 |
| 4579 | Red blood cell (erythrocyte) distribution width | Blood count | UKBB00000748 | 2.28 |
| 4580 | ITGB1BP2 levels | GCST90469642 | 2.28 |
| 4581 | Total testosterone levels | GCST90012112 | 2.28 |
| 4582 | Total lipids in very small VLDL (UKB data field 23517) | GCST90269614 | 2.28 |
| 4583 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007527 | 2.28 |
| 4584 | PM: initial answer - Orange circle| Prospective memory | UKBB00000652 | 2.27 |
| 4585 | CRYBB2 levels | GCST90468875 | 2.27 |
| 4586 | aparc-a2009s rh volume S-front-inf | GCST90003050 | 2.27 |
| 4587 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 39) | GCST90320858 | 2.26 |
| 4588 | Coronary artery bypass grafting | FING00000358 | 2.26 |
| 4589 | Platelet count at delivery | GCST90302227 | 2.26 |
| 4590 | X-24947 levels | GCST90200651 | 2.26 |
| 4591 | Linoleic acid to total fatty acids percentage | GCST90502332 | 2.26 |
| 4592 | PSAPL1 levels | GCST90242354 | 2.26 |
| 4593 | Other disorders of stomach and duodenum (PheCode 537) | GCST90476054 | 2.25 |
| 4594 | Age at onset of walking | GCST90651078 | 2.25 |
| 4595 | IDP dMRI TBSS MO Cerebral peduncle R | GCST90003966 | 2.25 |
| 4596 | KLK14 levels | GCST90469700 | 2.25 |
| 4597 | SPINK4 levels | GCST90470723 | 2.25 |
| 4598 | AmygNuclei lh volume Lateral-nucleus | GCST90002648 | 2.25 |
| 4599 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T414 | ECGA000414 | 2.24 |
| 4600 | Triglyceride levels in small VLDL | GCST90092978 | 2.24 |
| 4601 | Knee extension strength | GCST90319502 | 2.24 |
| 4602 | Diabetes (standard GWA) | GCST90267278 | 2.24 |
| 4603 | 3-Hydroxybutyrate levels | GCST90092811 | 2.24 |
| 4604 | aparc-pial rh area lingual | GCST90003186 | 2.24 |
| 4605 | Tobacco use disorder | mental disorders | UKBB00000824 | 2.24 |
| 4606 | Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500983 | 2.24 |
| 4607 | ICD10 O24.4: Diabetes mellitus arising in pregnancy | GCST90454236 | 2.23 |
| 4608 | CDHR2 levels | GCST90468679 | 2.23 |
| 4609 | aseg lh volume choroid-plexus | GCST90002629 | 2.23 |
| 4610 | Triglycerides to Total Lipids in Very Large VLDL percentage | GCST90500692 | 2.23 |
| 4611 | BTN2A1/SMOC2 ratio | GCST90313549 | 2.23 |
| 4612 | Biological Father: Coronary Artery / Coronary Heart Disease | GCST90475241 | 2.23 |
| 4613 | Diaphragmatic hernia | digestive | UKBB00000171 | 2.22 |
| 4614 | Androstenediol (3beta,17beta) monosulfate (1) levels | GCST90199872 | 2.22 |
| 4615 | LILRA5 levels | GCST90469774 | 2.22 |
| 4616 | Holdemania abundance in stool | GCST90032432 | 2.22 |
| 4617 | Cough (PheCode 512.8) | GCST90476041 | 2.22 |
| 4618 | NUB1 levels | GCST90470099 | 2.22 |
| 4619 | LGALS1/LGALS8 ratio | GCST90315314 | 2.22 |
| 4620 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T412 | ECGA000412 | 2.22 |
| 4621 | Triglycerides to Total Lipids in Large VLDL percentage | GCST90498287 | 2.22 |
| 4622 | PLA2G4A/PPP1R12A ratio | GCST90315666 | 2.22 |
| 4623 | Hemoglobin | GCST90002384 | 2.22 |
| 4624 | Colorectal cancer (PheCode 153) | GCST90475566 | 2.21 |
| 4625 | rfMRI connectivity ICA-features 3 | GCST90006341 | 2.21 |
| 4626 | wg rh intensity-contrast parsopercularis | GCST90003844 | 2.21 |
| 4627 | Left-hemisphere control network to right-hemisphere control network white-matter structural connectivity | GCST90302750 | 2.21 |
| 4628 | Nonalcoholic fatty liver disease | GCST90091033 | 2.21 |
| 4629 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90500905 | 2.21 |
| 4630 | CPA1/PRSS2 ratio | GCST90314206 | 2.21 |
| 4631 | Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483) | GCST90269580 | 2.21 |
| 4632 | Left-hemisphere default mode network to caudate white-matter structural connectivity | GCST90302768 | 2.20 |
| 4633 | GFER levels | GCST90469326 | 2.20 |
| 4634 | CCN3/FAP ratio | GCST90313721 | 2.20 |
| 4635 | MRAP levels | GCST90089910 | 2.20 |
| 4636 | Principal component-derived dietary pattern 39 | GCST90133044 | 2.20 |
| 4637 | PHYKPL levels | GCST90470228 | 2.20 |
| 4638 | Educational attainment | GCST002598 | 2.20 |
| 4639 | aseg lh intensity Cerebellum-Cortex | GCST90003767 | 2.20 |
| 4640 | Left-hemisphere visual network to left-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302651 | 2.19 |
| 4641 | DTI autoptx L2 cgc r tract | GCST90385171 | 2.19 |
| 4642 | IDP dMRI ProbtrackX OD ilf r | GCST90004465 | 2.19 |
| 4643 | Cancer (UKB data field 2453) | GCST90043628 | 2.19 |
| 4644 | IL1B levels | GCST90469570 | 2.19 |
| 4645 | Triglycerides to total lipids in medium HDL percentage (UKB data field 23643) | GCST90269740 | 2.19 |
| 4646 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T238 | ECGU000238 | 2.19 |
| 4647 | CHGA levels | GCST90468741 | 2.19 |
| 4648 | CLEC14A/TNFRSF21 ratio | GCST90314082 | 2.19 |
| 4649 | SKAP1 levels | GCST90470645 | 2.18 |
| 4650 | Melanoma in situ (controls excluding all cancers) | FING00000803 | 2.18 |
| 4651 | Calcific tendinitis of shoulder | FING00000235 | 2.18 |
| 4652 | P4HB/PPP1R12A ratio | GCST90315591 | 2.18 |
| 4653 | IDP dMRI ProbtrackX ISOVF unc l | GCST90004550 | 2.17 |
| 4654 | Current employment status - Doing unpaid or voluntary work | Employment | UKBB00000157 | 2.17 |
| 4655 | Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500958 | 2.17 |
| 4656 | IL1RAP levels | GCST90469573 | 2.17 |
| 4657 | Never eat eggs, dairy, wheat, sugar - I eat all of the above | Diet | UKBB00000500 | 2.17 |
| 4658 | Serine levels | GCST90200415 | 2.17 |
| 4659 | Mean corpuscular hemoglobin concentration | GCST90002329 | 2.17 |
| 4660 | aseg global volume CSF | GCST90002603 | 2.17 |
| 4661 | Phospholipids in IDL | GCST90497628 | 2.17 |
| 4662 | aparc-a2009s lh volume G-parietal-sup | GCST90002951 | 2.17 |
| 4663 | Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641) | GCST90269738 | 2.16 |
| 4664 | Glaucoma, exfoliation | FING00000580 | 2.16 |
| 4665 | Free androgen index | GCST90239823 | 2.16 |
| 4666 | Abnormal results of function study of liver (PheCode 573.7) | GCST90476097 | 2.15 |
| 4667 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T221 | ECGU000221 | 2.15 |
| 4668 | Non-cancer illness code, self-reported - hypertension | Medical conditions | UKBB00000517 | 2.15 |
| 4669 | Lymphoid neoplasms | GCST90624743 | 2.15 |
| 4670 | Open wound of foot except toe(s) alone (PheCode 871.3) | GCST90476286 | 2.15 |
| 4671 | TXNDC5 levels | GCST90470991 | 2.15 |
| 4672 | Diverticulitis (PheCode 562.2) | GCST90476077 | 2.15 |
| 4673 | COL6A3/NBL1 ratio | GCST90314176 | 2.15 |
| 4674 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T384 | ECGU000384 | 2.15 |
| 4675 | Cholesterol to total lipids in large VLDL percentage (UKB data field 23590) | GCST90269687 | 2.15 |
| 4676 | Stress incontinence, female | genitourinary | UKBB00000797 | 2.14 |
| 4677 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92) | GCST90320911 | 2.14 |
| 4678 | ASAH2 levels | GCST90242098 | 2.14 |
| 4679 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 59) | GCST90320878 | 2.14 |
| 4680 | PPP1R14D levels | GCST90470303 | 2.14 |
| 4681 | Acne (PheCode 706.1) | GCST90476211 | 2.14 |
| 4682 | Unstable angina pectoris | FING00001405 | 2.13 |
| 4683 | Plasma ascorbic acid 2-sulfate levels in chronic kidney disease | GCST90264832 | 2.13 |
| 4684 | CDKN1A/FXN ratio | GCST90313971 | 2.13 |
| 4685 | Pustulosis palmaris et plantaris | FING00001233 | 2.13 |
| 4686 | Hearing difficulty | GCST90245774 | 2.13 |
| 4687 | Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501050 | 2.13 |
| 4688 | aseg global intensity 4th-Ventricle | GCST90003752 | 2.13 |
| 4689 | Triglycerides in medium HDL (UKB data field 23571) | GCST90269668 | 2.13 |
| 4690 | Bone marrow fat fraction of thoracic vertebra 9 | GCST90652381 | 2.13 |
| 4691 | Fracture of upper limb (PheCode 803) | GCST90476279 | 2.13 |
| 4692 | IDP dMRI ProbtrackX OD slf l | GCST90004471 | 2.13 |
| 4693 | Cholesteryl Esters in IDL | GCST90497523 | 2.13 |
| 4694 | BA-exvivo rh area BA4p | GCST90003226 | 2.13 |
| 4695 | Aplastic anemia (PheCode 284) | GCST90475783 | 2.13 |
| 4696 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T404 | ECGU000404 | 2.13 |
| 4697 | Other chronic ischemic heart disease, unspecified | circulatory system | UKBB00000603 | 2.12 |
| 4698 | FOLR2/MSR1 ratio | GCST90314866 | 2.12 |
| 4699 | Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels | GCST90060254 | 2.12 |
| 4700 | Feeling tense | GCST006952 | 2.12 |
| 4701 | Monounsaturated fatty acid levels | GCST90092928 | 2.12 |
| 4702 | Hemoglobin | GCST90018737 | 2.12 |
| 4703 | Osteoporosis NOS (PheCode 743.11) | GCST90476260 | 2.12 |
| 4704 | Current Smoker | FING00000371 | 2.12 |
| 4705 | Concentration of very small VLDL particles (UKB data field 23516) | GCST90269613 | 2.12 |
| 4706 | T1 FreeSurfer pial rh pericalcarine area | GCST90385842 | 2.11 |
| 4707 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57) | GCST90320620 | 2.11 |
| 4708 | Nonspecific chest pain (PheCode 418) | GCST90475947 | 2.11 |
| 4709 | IDP dMRI TBSS ICVF Sagittal stratum R | GCST90004357 | 2.11 |
| 4710 | IDP dMRI TBSS MD Cingulum hippocampus L | GCST90004064 | 2.11 |
| 4711 | GGH/INHBC ratio | GCST90314928 | 2.11 |
| 4712 | Triglycerides to Total Lipids in Very Large VLDL percentage | GCST90500695 | 2.11 |
| 4713 | DTI autoptx FA ifo r tract | GCST90385125 | 2.11 |
| 4714 | DNER levels | GCST90274785 | 2.11 |
| 4715 | Metabolonic lactone sulfate levels | GCST90200257 | 2.11 |
| 4716 | CCBL2 levels | GCST90241722 | 2.11 |
| 4717 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T69 | ECGA000069 | 2.11 |
| 4718 | Left bundle branch block (PheCode 426.32) | GCST90475958 | 2.11 |
| 4719 | Left-hemisphere somatomotor network to amygdala white-matter structural connectivity | GCST90302687 | 2.10 |
| 4720 | aseg lh intensity VentralDC | GCST90003775 | 2.10 |
| 4721 | aseg global volume 4th-Ventricle | GCST90002600 | 2.10 |
| 4722 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T381 | ECGU000381 | 2.10 |
| 4723 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T383 | ECGU000383 | 2.10 |
| 4724 | ROBO2/SCARF2 ratio | GCST90315784 | 2.10 |
| 4725 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T430 | ECGU000430 | 2.09 |
| 4726 | Ratio of triglycerides to phosphoglycerides | GCST90092983 | 2.09 |
| 4727 | Diacylglycerol_36:2_[M+H-H2O]1+ levels | GCST90060191 | 2.09 |
| 4728 | Shoulder lesions | Other soft tissue disorders | UKBB00000769 | 2.09 |
| 4729 | SMOC2 levels | GCST90470683 | 2.09 |
| 4730 | IDP dMRI TBSS L2 Body of corpus callosum | GCST90004126 | 2.09 |
| 4731 | IDP dMRI ProbtrackX ISOVF ilf r | GCST90004540 | 2.09 |
| 4732 | Osteoporosis (PheCode 743.1) | GCST90476259 | 2.09 |
| 4733 | DTI TBSS L2 Splenium of corpus callosum | GCST90384480 | 2.09 |
| 4734 | Colon cancer/rectal cancer | GCST90475170 | 2.08 |
| 4735 | Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500956 | 2.08 |
| 4736 | IDP dMRI TBSS FA Superior corona radiata R | GCST90003901 | 2.08 |
| 4737 | Medication use (vasodilators used in cardiac diseases) | GCST90018763 | 2.08 |
| 4738 | GBA1 levels | GCST90423262 | 2.08 |
| 4739 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T187 | ECGU000187 | 2.08 |
| 4740 | Autorefraction - 6mm asymmetry angle (left) | Eyesight | UKBB00000072 | 2.08 |
| 4741 | Succinoyltaurine levels | GCST90200235 | 2.08 |
| 4742 | Autorefraction - 3mm cylindrical power angle (left) | Eyesight | UKBB00000064 | 2.07 |
| 4743 | PRKG1 levels | GCST90470330 | 2.07 |
| 4744 | Non-cancer illness code, self-reported - kidney stone/ureter stone/bladder stone | Medical conditions | UKBB00000519 | 2.07 |
| 4745 | PNLIPRP1 levels | GCST90470273 | 2.07 |
| 4746 | TDGF1 levels | GCST90470824 | 2.07 |
| 4747 | Right ventricular peak ejection rate | GCST90268120 | 2.07 |
| 4748 | Dermatophytosis of nail (PheCode 110.11) | GCST90475562 | 2.07 |
| 4749 | Cholesterol to Total Lipids in Large VLDL percentage | GCST90498125 | 2.07 |
| 4750 | CD300LG/CLEC14A ratio | GCST90313801 | 2.07 |
| 4751 | IDP T1 FAST ROIs R cerebellum X | GCST90002589 | 2.06 |
| 4752 | Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2) | GCST90476004 | 2.06 |
| 4753 | Fibrosis and cirrhosis of liver | FING00000543 | 2.06 |
| 4754 | wg rh intensity-contrast caudalmiddlefrontal | GCST90003830 | 2.06 |
| 4755 | CLEC5A levels | GCST90468776 | 2.06 |
| 4756 | mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed) | GCST90475454 | 2.06 |
| 4757 | Salt added to food | Diet | UKBB00000762 | 2.06 |
| 4758 | HYOU1/TGFBR3 ratio | GCST90315105 | 2.05 |
| 4759 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82) | GCST90320645 | 2.05 |
| 4760 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T191 | ECGU000191 | 2.05 |
| 4761 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T398 | ECGA000398 | 2.05 |
| 4762 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06) | GCST90291582 | 2.05 |
| 4763 | T1 CAT volume L LateralOccipitalCortexinferiordivision | GCST90384044 | 2.05 |
| 4764 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42) | GCST90320861 | 2.05 |
| 4765 | Non-oily fish consumption | GCST90132994 | 2.04 |
| 4766 | FCER1A levels | GCST90469198 | 2.04 |
| 4767 | Triglycerides in medium VLDL (UKB data field 23508) | GCST90269605 | 2.04 |
| 4768 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T181 | ECGU000181 | 2.04 |
| 4769 | Phospholipids to Total Lipids in Very Large VLDL percentage | GCST90500665 | 2.04 |
| 4770 | Triglyceride levels (UKB data field 30870) | GCST90468106 | 2.04 |
| 4771 | Left molecular layer hippocampal volume (body) | GCST90267953 | 2.04 |
| 4772 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T174 | ECGU000174 | 2.04 |
| 4773 | CA1/CA2 ratio | GCST90313571 | 2.04 |
| 4774 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T392 | ECGA000392 | 2.04 |
| 4775 | Red cell distribution width | GCST90002369 | 2.04 |
| 4776 | Coronary angioplasty | FING00000357 | 2.03 |
| 4777 | IDP dMRI TBSS ISOVF Posterior thalamic radiation R | GCST90004505 | 2.03 |
| 4778 | FST levels | GCST90469273 | 2.03 |
| 4779 | Coronary atherosclerosis | circulatory system | UKBB00000152 | 2.03 |
| 4780 | Parental longevity (mother's attained age) | GCST006696 | 2.03 |
| 4781 | Dermatochalasis (PheCode 374.6) | GCST90475894 | 2.02 |
| 4782 | Frontal QRS-T angle | GCST90246321 | 2.02 |
| 4783 | aparc-a2009s lh thickness G-cuneus | GCST90003613 | 2.02 |
| 4784 | ACY1/DCXR ratio | GCST90313162 | 2.02 |
| 4785 | aparc-Desikan rh thickness GlobalMeanThickness | GCST90003479 | 2.02 |
| 4786 | Free cholesterol in large VLDL (UKB data field 23500) | GCST90269597 | 2.02 |
| 4787 | NPY/SMOC1 ratio | GCST90315551 | 2.01 |
| 4788 | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | GCST90004116 | 2.01 |
| 4789 | IDP dMRI TBSS OD Cerebral peduncle R | GCST90004416 | 2.01 |
| 4790 | Triglyceride levels in small HDL | GCST90092954 | 2.01 |
| 4791 | aparc-DKTatlas lh area lingual | GCST90003245 | 2.01 |
| 4792 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T397 | ECGA000397 | 2.01 |
| 4793 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T418 | ECGU000418 | 2.01 |
| 4794 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T380 | ECGU000380 | 2.01 |
| 4795 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T397 | ECGU000397 | 2.01 |
| 4796 | TSPAN8 levels | GCST90470980 | 2.01 |
| 4797 | COMP/ITGAV ratio | GCST90314190 | 2.00 |
| 4798 | KLK8 levels | GCST90241680 | 2.00 |
| 4799 | SRC/TBL1X ratio | GCST90315884 | 2.00 |
| 4800 | BANK1/FOXO1 ratio | GCST90313456 | 2.00 |
| 4801 | Aplastic anemia | GCST90018574 | 2.00 |
| 4802 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T230 | ECGU000230 | 2.00 |
| 4803 | APEX1 levels | GCST90468329 | 2.00 |
| 4804 | S100A4/SNAP29 ratio | GCST90315801 | 2.00 |
| 4805 | ICD10 N92: Excessive, frequent and irregular menstruation | GCST90454221 | 2.00 |
| 4806 | Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486) | GCST90269583 | 2.00 |
| 4807 | THY1 levels | GCST90470861 | 1.99 |
| 4808 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T382 | ECGU000382 | 1.99 |
| 4809 | EDIL3 levels | GCST90469072 | 1.99 |
| 4810 | Triglyceride to HDL cholesterol ratio | GCST90295950 | 1.99 |
| 4811 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T461 | ECGU000461 | 1.98 |
| 4812 | FBP1 levels | GCST90469195 | 1.98 |
| 4813 | GGT1 levels | GCST90469336 | 1.98 |
| 4814 | Treatment/medication code - lansoprazole | Medications | UKBB00000848 | 1.98 |
| 4815 | wg rh intensity-contrast superiorfrontal | GCST90003854 | 1.98 |
| 4816 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T232 | ECGA000232 | 1.97 |
| 4817 | Cholesterol in Large VLDL | GCST90498119 | 1.97 |
| 4818 | Urine dimethylglycine levels in chronic kidney disease | GCST90265045 | 1.97 |
| 4819 | CALCOCO1/DCTN1 ratio | GCST90313600 | 1.97 |
| 4820 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T403 | ECGU000403 | 1.97 |
| 4821 | CXADR/GGT1 ratio | GCST90314328 | 1.97 |
| 4822 | ART3/RGMA ratio | GCST90313362 | 1.97 |
| 4823 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T457 | ECGA000457 | 1.97 |
| 4824 | MAPK9 levels | GCST90469857 | 1.97 |
| 4825 | ADGRE5/VCAM1 ratio | GCST90313184 | 1.97 |
| 4826 | ENO2/TXNDC5 ratio | GCST90314671 | 1.96 |
| 4827 | wg rh intensity-contrast temporalpole | GCST90003859 | 1.96 |
| 4828 | wg lh intensity-contrast lingual | GCST90003804 | 1.96 |
| 4829 | Attention deficit hyperactivity disorder (ADuLT model adjusted for sex) | GCST90275136 | 1.96 |
| 4830 | IDP dMRI ProbtrackX ICVF ifo r | GCST90004388 | 1.96 |
| 4831 | aparc-DKTatlas rh volume parsopercularis | GCST90002909 | 1.96 |
| 4832 | Pelvic organ prolapse | GCST90102470 | 1.96 |
| 4833 | PPP1R14A levels | GCST90470302 | 1.96 |
| 4834 | Types of transport used (excluding work) - Cycle | Physical activity | UKBB00000877 | 1.96 |
| 4835 | Total fatty acid levels | GCST90502727 | 1.95 |
| 4836 | CNTN3/NCS1 ratio | GCST90314165 | 1.95 |
| 4837 | IDP dMRI TBSS OD External capsule R | GCST90004434 | 1.95 |
| 4838 | Frailty (Factor 2 - Unhealthy Lifestyle) | GCST90624048 | 1.95 |
| 4839 | ZBTB16 levels | GCST90471095 | 1.95 |
| 4840 | Autorefraction - 6mm asymmetry index (right) | Eyesight | UKBB00000074 | 1.95 |
| 4841 | total creatine kinase (minimum, inv-norm transformed) | GCST90476416 | 1.95 |
| 4842 | ANPEP/CXADR ratio | GCST90313272 | 1.95 |
| 4843 | PLAU levels | GCST90470252 | 1.95 |
| 4844 | Total Lipids in VLDL | GCST90500234 | 1.94 |
| 4845 | aparc-DKTatlas rh area lingual | GCST90003276 | 1.94 |
| 4846 | X-21467 levels | GCST90200594 | 1.94 |
| 4847 | Ventral hernia | FING00001428 | 1.94 |
| 4848 | Fractured bone site(s) - Wrist | Medical conditions | UKBB00000257 | 1.94 |
| 4849 | mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed) | GCST90475462 | 1.94 |
| 4850 | CD27/TNFRSF13B ratio | GCST90313777 | 1.94 |
| 4851 | N-acetylmethionine levels | GCST90200289 | 1.94 |
| 4852 | MINK1 levels | GCST90469909 | 1.93 |
| 4853 | SDK2 levels | GCST90470562 | 1.93 |
| 4854 | Attention deficit hyperactivity disorder | GCST005362 | 1.93 |
| 4855 | Triglycerides to Total Lipids in Medium HDL percentage | GCST90498689 | 1.93 |
| 4856 | PVR levels | GCST90470394 | 1.93 |
| 4857 | IDP dMRI ProbtrackX FA ar r | GCST90003926 | 1.93 |
| 4858 | SYT1 levels | GCST90470794 | 1.93 |
| 4859 | Diabetes diagnosed by doctor | Medical conditions | UKBB00000168 | 1.93 |
| 4860 | NUCB2/TXNDC5 ratio | GCST90315578 | 1.93 |
| 4861 | PROC levels | GCST90470335 | 1.93 |
| 4862 | Autorefraction - 3mm weak meridian angle (left) | Eyesight | UKBB00000071 | 1.93 |
| 4863 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T481 | ECGU000481 | 1.93 |
| 4864 | PDCD6 levels | GCST90470183 | 1.92 |
| 4865 | Colon cancer (PheCode 153.2) | GCST90475567 | 1.92 |
| 4866 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T469 | ECGU000469 | 1.92 |
| 4867 | S100A11/SERPINB8 ratio | GCST90315799 | 1.92 |
| 4868 | DNAJB1/SIRT2 ratio | GCST90314511 | 1.92 |
| 4869 | Hematocrit | GCST90002304 | 1.92 |
| 4870 | GFRA3 levels | GCST90469330 | 1.92 |
| 4871 | Left-hemisphere limbic network to right-hemisphere default mode network white-matter structural connectivity | GCST90302735 | 1.92 |
| 4872 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T468 | ECGA000468 | 1.92 |
| 4873 | MPHOSPH8/PSRC1 ratio | GCST90315478 | 1.92 |
| 4874 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T183 | ECGU000183 | 1.92 |
| 4875 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | GCST90475458 | 1.92 |
| 4876 | Total lipids in large LDL | GCST90498011 | 1.91 |
| 4877 | HMOX2 levels | GCST90469466 | 1.91 |
| 4878 | Alanine levels | GCST90243582 | 1.91 |
| 4879 | GSTA1/PBLD ratio | GCST90314994 | 1.91 |
| 4880 | Docosahexaenoic acid levels | GCST90502255 | 1.91 |
| 4881 | CDKN1A/NCK2 ratio | GCST90313973 | 1.91 |
| 4882 | IDP dMRI ProbtrackX L3 cgc r | GCST90004305 | 1.90 |
| 4883 | CNTN4 levels | GCST90468806 | 1.90 |
| 4884 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T287 | ECGU000287 | 1.90 |
| 4885 | ZNRF4 levels | GCST90471104 | 1.90 |
| 4886 | 1-stearoyl-GPE (18:0) levels | GCST90199772 | 1.90 |
| 4887 | Abnormal heart sounds (PheCode 396) | GCST90475916 | 1.90 |
| 4888 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T371 | ECGU000371 | 1.90 |
| 4889 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T468 | ECGU000468 | 1.90 |
| 4890 | Systolic blood pressure (MTAG) | GCST90449056 | 1.90 |
| 4891 | HNRNPAB levels | GCST90088693 | 1.90 |
| 4892 | How many years have you or did you smoke cigarettes? (inv-normal transformed) | GCST90476390 | 1.90 |
| 4893 | Osteoarthrosis | musculoskeletal | UKBB00000596 | 1.90 |
| 4894 | Degree of unsaturation | GCST90502737 | 1.89 |
| 4895 | Atrial fibrillation and flutter (PheCode 427.2) | GCST90043977 | 1.89 |
| 4896 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7 | ECGA000007 | 1.89 |
| 4897 | CFD levels | GCST90468725 | 1.89 |
| 4898 | DTI TBSS MD Cingulum hippocampus L | GCST90384609 | 1.89 |
| 4899 | PALM levels | GCST90470154 | 1.89 |
| 4900 | Bundle branch block (PheCode 426.3) | GCST90475956 | 1.89 |
| 4901 | Body mass index | GCST90018727 | 1.89 |
| 4902 | Illnesses of father - Heart disease | Family history | UKBB00000342 | 1.89 |
| 4903 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T288 | ECGU000288 | 1.89 |
| 4904 | APP/HBEGF ratio | GCST90313324 | 1.89 |
| 4905 | wg lh intensity-contrast bankssts | GCST90003793 | 1.88 |
| 4906 | Scoliosis | FING00001281 | 1.88 |
| 4907 | CD46/NECTIN2 ratio | GCST90313832 | 1.88 |
| 4908 | DTI autoptx L1 fmi tract | GCST90385150 | 1.88 |
| 4909 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T286 | ECGU000286 | 1.88 |
| 4910 | Waist-hip index | GCST90020027 | 1.88 |
| 4911 | Phospholipid levels in large VLDL | GCST90092876 | 1.88 |
| 4912 | IGFBP6/SMOC2 ratio | GCST90315138 | 1.88 |
| 4913 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T372 | ECGU000372 | 1.88 |
| 4914 | Left ventricular wall thickness (maximal) | GCST90435263 | 1.88 |
| 4915 | COL5A1 levels | GCST90468820 | 1.87 |
| 4916 | 1-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levels | GCST90200057 | 1.87 |
| 4917 | Marzipan liking | GCST90094797 | 1.87 |
| 4918 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T471 | ECGA000471 | 1.87 |
| 4919 | Ambidextrousness | GCST90013420 | 1.87 |
| 4920 | CA14 levels | GCST90468509 | 1.87 |
| 4921 | Descending aorta distensibility | GCST90267386 | 1.87 |
| 4922 | Inguinal hernia | FING00000681 | 1.87 |
| 4923 | AXIN1/MAVS ratio | GCST90313414 | 1.87 |
| 4924 | ADGRD1 levels | GCST90468235 | 1.87 |
| 4925 | Vascular/heart problems diagnosed by doctor - None of the above | Medical conditions | UKBB00000899 | 1.86 |
| 4926 | CNTNAP2/DPP10 ratio | GCST90314167 | 1.86 |
| 4927 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T419 | ECGU000419 | 1.86 |
| 4928 | Dorsalgia | FING00000472 | 1.86 |
| 4929 | DTI TBSS L1 Superior longitudinal fasciculus L | GCST90384469 | 1.86 |
| 4930 | Coffee type - Ground coffee (include espresso, filter etc) | Diet | UKBB00000140 | 1.86 |
| 4931 | CKMT1A or CKMT1B levels | GCST90468760 | 1.86 |
| 4932 | IDP dMRI ProbtrackX MD ptr l | GCST90004238 | 1.86 |
| 4933 | Plasma 2-aminobutyrate levels in chronic kidney disease | GCST90264339 | 1.86 |
| 4934 | IDP dMRI ProbtrackX ICVF ilf r | GCST90004390 | 1.86 |
| 4935 | Concentration of large VLDL particles | GCST90498223 | 1.86 |
| 4936 | 1-methylhistidine metabolite level | GCST90615480 | 1.85 |
| 4937 | Total testosterone levels | GCST90012113 | 1.85 |
| 4938 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91) | GCST90320654 | 1.85 |
| 4939 | IDP dMRI TBSS MD Cingulum cingulate gyrus L | GCST90004062 | 1.85 |
| 4940 | DSG2 levels | GCST90469042 | 1.85 |
| 4941 | HMBS/PKLR ratio | GCST90315063 | 1.85 |
| 4942 | Sleep duration | Sleep | UKBB00000777 | 1.85 |
| 4943 | Prescriptions - gliclazide | sulfonylurea,diabetes | UKBB00000684 | 1.85 |
| 4944 | Use of hypnotics and sedatives | FING00001411 | 1.84 |
| 4945 | COQ7 levels | GCST90468831 | 1.84 |
| 4946 | Triacylglycerol_54:5_[M+NH4]1+ levels | GCST90060539 | 1.84 |
| 4947 | DTI autoptx MD atr r tract | GCST90385223 | 1.84 |
| 4948 | Histidine levels | GCST90497481 | 1.84 |
| 4949 | Alzheimer's disease (MTAG) | GCST90449060 | 1.84 |
| 4950 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 25) | GCST90320588 | 1.84 |
| 4951 | APOM levels | GCST90468342 | 1.84 |
| 4952 | wg lh intensity-contrast parstriangularis | GCST90003811 | 1.83 |
| 4953 | Coffee type: Ground coffee (include espresso, filter etc) (UKB data field 1508_3) | GCST90041803 | 1.83 |
| 4954 | Concentration of very large VLDL particles | GCST90500631 | 1.83 |
| 4955 | Plasma X-24947 levels in chronic kidney disease | GCST90266816 | 1.83 |
| 4956 | QC rfMRI-to-T1 linear alignment discrepancy | GCST90006353 | 1.83 |
| 4957 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T176 | ECGU000176 | 1.83 |
| 4958 | Gestational age at birth (child effect) | GCST90268421 | 1.83 |
| 4959 | aparc-Desikan rh area lingual | GCST90003119 | 1.83 |
| 4960 | Blood urea nitrogen (BUN, maximum, inv-norm transformed) | GCST90475162 | 1.83 |
| 4961 | ITGA2 levels | GCST90469634 | 1.83 |
| 4962 | ICD10 N91.0, N91.1, N91.2: Amenorrhea, including primary amenorrhea, secondary amenorrhea and unspecified amenorrhea | GCST90454219 | 1.83 |
| 4963 | Phospholipids in LDL | GCST90498432 | 1.82 |
| 4964 | Triglyceride levels in HDL | GCST90092829 | 1.82 |
| 4965 | FLT1/TGFB1 ratio | GCST90314857 | 1.82 |
| 4966 | Gastric ulcer | GCST90018631 | 1.82 |
| 4967 | Other peripheral nerve disorders | neurological | UKBB00000618 | 1.82 |
| 4968 | CST3/EFEMP1 ratio | GCST90314292 | 1.81 |
| 4969 | Triglycerides to Total Lipids in Small VLDL percentage | GCST90499922 | 1.81 |
| 4970 | Sleep apnea syndrome | GCST90267361 | 1.81 |
| 4971 | Moderate visual impairment, binocular | FING00000831 | 1.81 |
| 4972 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 114) | GCST90320677 | 1.81 |
| 4973 | DKKL1 levels | GCST90469000 | 1.81 |
| 4974 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T186 | ECGU000186 | 1.81 |
| 4975 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T401 | ECGU000401 | 1.81 |
| 4976 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T254 | ECGU000254 | 1.81 |
| 4977 | KRT19 levels | GCST90469717 | 1.81 |
| 4978 | CD160/KLRB1 ratio | GCST90313731 | 1.81 |
| 4979 | Hematocrit | GCST90002383 | 1.80 |
| 4980 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T465 | ECGA000465 | 1.80 |
| 4981 | Alcohol use and misuse (confirmatory factor analysis Factor 22) | GCST90309356 | 1.80 |
| 4982 | Operation code - carpal tunnel surgery | Operations | UKBB00000553 | 1.80 |
| 4983 | Types of transport used (excluding work) - Public transport | Physical activity | UKBB00000878 | 1.80 |
| 4984 | Left-hemisphere control network to right-hemisphere visual network white-matter structural connectivity | GCST90302745 | 1.80 |
| 4985 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90500975 | 1.80 |
| 4986 | Lymphangioleiomyomatosis (sporadic) | GCST008311 | 1.80 |
| 4987 | Total bilirubin levels | GCST90278643 | 1.80 |
| 4988 | Chronic obstructive pulmonary disease x ever smoker interaction (main effect) | GCST90016586 | 1.80 |
| 4989 | Breast cancer | GCST90011804 | 1.80 |
| 4990 | TFF3 levels | GCST90470837 | 1.79 |
| 4991 | BCAT1 levels | GCST90468427 | 1.79 |
| 4992 | IDP T1 SIENAX brain-normalised volume | GCST90002434 | 1.79 |
| 4993 | APOF levels | GCST90468339 | 1.79 |
| 4994 | CD33 levels | GCST90468625 | 1.79 |
| 4995 | Triacylglycerol_50:5_[M+NH4]1+ levels | GCST90060463 | 1.79 |
| 4996 | ARHGEF10 levels | GCST90468357 | 1.79 |
| 4997 | Average diameter for LDL particles | GCST90092889 | 1.78 |
| 4998 | AmygNuclei rh volume Paralaminar-nucleus | GCST90002666 | 1.78 |
| 4999 | PENK levels | GCST90470208 | 1.78 |
| 5000 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T233 | ECGA000233 | 1.78 |